Khiron Life Sciences Corp. announced that its wholly owned subsidiary Zerenia Colombia has closed an unsecured revolving credit facility of CAD 580,000 with a private financing company in Colombia. The 12-month revolving credit facility became effective on February 10, 2023, and was provided by a Colombian private financing company.

The company was granted this working capital credit line after having established a relationship with the financing company over the past year. Khiron's unique business model with a growing patient base has been strengthened by the recent accomplishments including mandatory insurance coverage in Colombia, NHS coverage in the UK, and the engagement of Colombia's large public insurance company, Capital Salud. The unsecured revolving credit line provided to Zerenia SAS bears an annual interest rate of DTF + 10.5%.